DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Reck M, Mok TS, Nishio M, Jotte RM, Cappuzzo F, Orlandi F. et al.
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): Key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.

Lancet Respir Med 2019;
7: 387-401

Download Bibliographical Data

Access:
Access: